Edap Tms SA (NASDAQ:EDAP) saw a large decrease in short interest during the month of December. As of December 29th, there was short interest totalling 349,250 shares, a decrease of 36.5% from the December 15th total of 549,939 shares. Based on an average trading volume of 89,894 shares, the days-to-cover ratio is currently 3.9 days.
A number of hedge funds and other institutional investors have recently bought and sold shares of EDAP. Archon Capital Management LLC bought a new position in shares of Edap Tms during the 2nd quarter worth approximately $2,474,000. Essex Investment Management Co. LLC grew its stake in shares of Edap Tms by 520.2% during the 3rd quarter. Essex Investment Management Co. LLC now owns 323,528 shares of the medical equipment provider’s stock worth $964,000 after acquiring an additional 271,367 shares in the last quarter. Finally, Virtu KCG Holdings LLC bought a new position in shares of Edap Tms during the 2nd quarter worth approximately $117,000. 10.32% of the stock is owned by institutional investors and hedge funds.
A number of analysts have recently commented on EDAP shares. Zacks Investment Research raised Edap Tms from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 25th. ValuEngine cut Edap Tms from a “hold” rating to a “sell” rating in a research note on Friday, November 10th. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $6.50 price target on shares of Edap Tms in a research note on Wednesday, November 22nd.
Edap Tms (NASDAQ:EDAP) last posted its earnings results on Wednesday, November 15th. The medical equipment provider reported ($0.02) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.02). Edap Tms had a positive return on equity of 7.85% and a negative net margin of 5.36%. The business had revenue of $8.44 million during the quarter, compared to analysts’ expectations of $11.05 million. Edap Tms’s revenue was down 5.6% on a year-over-year basis. analysts anticipate that Edap Tms will post -0.01 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Short Interest in Edap Tms SA (EDAP) Decreases By 36.5%” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://stocknewstimes.com/2018/02/11/edap-tms-sa-edap-sees-significant-decline-in-short-interest.html.
Edap Tms Company Profile
EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.